IVA Inventiva S.A.

3.471USD3.165 EUR · EPA+8.39%Mkt Cap: 830.01M USDP/E: —

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in F…